The study by Henrikson and colleagues in this issue is an important addition to the evidence on the diagnostic value of chest pain relief by nitroglycerin. The response to sublingual nitroglycerin had no diagnostic value in patients who developed chest pain (presumably at rest) under medical supervision after admission. Do these findings mean that we should stop using the response to nitroglycerin to help diagnose patients with chronic chest pain?
|Original language||English (US)|
|Number of pages||2|
|Journal||Annals of internal medicine|
|State||Published - Dec 16 2003|
ASJC Scopus subject areas
- Internal Medicine